Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Stellence Life Sciences Private Limited, was an unlisted private company incorporated on 31 July, 2019. It is classified as a private limited company and is located in , Karnataka. It's authorized share capital was INR 15.00 lac and the total paid-up capital was INR 10,000.00 .
The current status of Stellence Life Sciences Private Limited is - Strike Off.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2024 numbers.
9.29%
7.69%
-68.97%
2.15%
6.23%
5.07%
5.57
-0.31
-8.37
-8.01
-0.76
0.01
No Reports Available
Tofler currently has no financial reports
for this company due to a lack of available
information. This may be because the company
is dormant or closed (see company status)
or because it was formed only recently
(check the incorporation date) and financial data
is not yet available.
You can view basic information by scrolling through the page.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(1)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Jyothinagaravyasha Sriraman Ramaprasad | 00173696 | 5 years |
| Director | Chandrappa Seetharamaiah | 07405773 | 4 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| NETEQUITY VENTURES PRIVATE LIMITED |
Amalgamated
|
6.0 L | 1 | Karnataka |
| HYDRA ACTIVE PHARMA SCIENCES PRIVATE LIMITED |
Active
|
131.3 Cr | 2 | Karnataka |
| BLUSKILLS EDUCATION PRIVATE LIMITED |
Dissolved
|
4.5 Cr | 1 | Karnataka |
| CARYL PHARMA PRIVATE LIMITED |
Amalgamated
|
43.5 L | 1 | Karnataka |
| SANTO PROPERTIES PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| TAITAI RESTAURANTS PRIVATE LIMITED |
Strike Off
|
3.7 Cr | 1 | Karnataka |
| PATSYS CONSULTING PRIVATE LIMITED |
Amalgamated
|
5.5 Cr | 1 | Delhi |
| LATITUDE PROJECTS PRIVATE LIMITED |
Strike Off
|
4.0 Cr | 1 | Karnataka |
| SKANRAY HEALTHCARE GLOBAL PRIVATE LIMITED |
Active
|
66.0 Cr | 2 | Karnataka |
| FRAXIS LIFE SCIENCES LIMITED |
Amalgamated
|
2.0 Cr | 1 | Maharashtra |
| TENSHI HEALTHCARE PRIVATE LIMITED |
Strike Off
|
10,000.0 | 2 | Tamil Nadu |
| TENSHI KSM PRIVATE LIMITED |
Under Liquidation
|
82.8 L | 2 | Karnataka |
| FARMGENUS PRIVATE LIMITED |
Active
|
2.1 Cr | 2 | Karnataka |
| KARUNA VENTURES PRIVATE LIMITED |
Active
|
7.0 L | 1 | Karnataka |
| SEQUENT SPECIALTY CHEMICALS PRIVATE LIMITED |
Dissolved
|
7.9 Cr | 1 | Karnataka |
| XLENSEA PRODUCTS PRIVATE LIMITED |
Amalgamated
|
1.0 L | 1 | Karnataka |
| PRONOMZ HOLDINGS PRIVATE LIMITED |
Active
|
1.0 L | 2 | Karnataka |
| RIVELA DEVELOPERS LLP |
Strike Off
|
1.5 L | 1 | Kerala |
| ARK LIFE SKILLS LLP |
Strike Off
|
1.0 L | 1 | Nadu |
| TRIUMPH VENTURE HOLDINGS LLP |
Active
|
1.0 L | 2 | Karnataka |
| DEVICAM CAPITAL LLP |
Active
|
18.0 Cr | 1 | Karnataka |
| CHAYADEEP PHARMA ALLIANCE LLP |
Active
|
1.0 L | 1 | Karnataka |
| KONUT LLP |
Active
|
1.0 L | 1 | Karnataka |
| ATMA ENTERPRISES LLP |
Active
|
1.0 L | 2 | Karnataka |
| CHAYADEEP VENTURES LLP |
Active
|
1.0 L | 2 | Karnataka |
| AGNUS CAPITAL LLP |
Active
|
1.0 L | 2 | Karnataka |
| QUALICHEM REMEDIES LLP |
Active
|
1.0 L | 2 | Karnataka |
| PRONOMZ VENTURES LLP |
Active
|
529.8 Cr | 2 | Karnataka |
| SKANRAY HEALTHCARE PARTNERS LLP |
Active
|
2.0 L | 2 | Karnataka |
| TENSHI VENTURES LLP |
Active
|
24.0 Cr | 2 | Karnataka |
| AGNUS VENTURES LLP |
Active
|
30.0 Cr | 2 | Karnataka |
| PLUSTWO BUSINESS SOLUTIONS LLP |
Active
|
1.0 L | 1 | Karnataka |
| SIX RAYS PHARMA SOLUTIONS LLP |
Active
|
20,000.0 | 2 | Karnataka |
| SIX RAYS LLP |
Active
|
10,010.0 | 2 | Karnataka |
| KARUNA BUSINESS SOLUTIONS LLP |
Active
|
3.0 L | 1 | Karnataka |
| SOVIZEN LIFE SCIENCES PRIVATE LIMITED |
Active
|
3.1 Cr | 1 | Karnataka |
| TENSHI KAIZEN PRIVATE LIMITED |
Active
|
11.6 Cr | 1 | Karnataka |
| EMERGE VOCATIONAL SKILLS PRIVATE LIMITED |
Active
|
7.6 Cr | 1 | Tamil Nadu |
| NATURALT BIOMATERIALS PRIVATE LIMITED |
Active
|
75,000.0 | 1 | Karnataka |
| FOURSQUARE PHARMA SOLUTIONS LLP |
Active
|
20,000.0 | 1 | Karnataka |
| STERISCIENCE SPECIALTIES PRIVATE LIMITED |
Active
|
2.1 L | 1 | Maharashtra |
| NAARI PHARMA PRIVATE LIMITED |
Active
|
2.7 Cr | 1 | Karnataka |
| TENSHI LIFE SCIENCES PRIVATE LIMITED |
Amalgamated
|
443.2 Cr | 1 | Tamil Nadu |
The incorporation date of STELLENCE LIFE SCIENCES PRIVATE LIMITED is 31 July, 2019
The authorized share capital of STELLENCE LIFE SCIENCES PRIVATE LIMITED is INR ₹ 15.0 L.
The paid-up capital of STELLENCE LIFE SCIENCES PRIVATE LIMITED is INR ₹ 10,000.0 .
The registered address of STELLENCE LIFE SCIENCES PRIVATE LIMITED is Plot No.30, 1st Main Road J P Nagar, Third Phase Bangalore Bangalore Karnataka - 560078
The CIN number of STELLENCE LIFE SCIENCES PRIVATE LIMITED is U24299KA2019PTC126688.
Expand
Delete
Collapse
See
details
